Antony Mattessich | President and CEO |
Donald Notman | CFO |
Scott Corning | SVP, Commercial |
Michael Goldstein | CMO |
Dan Leone | Raymond James |
Yi Chen | H.C. Wainwright |
Good afternoon, ladies and gentlemen. Thank you for standing by. And welcome to the Ocular Therapeutix First Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time.